Scar formation following injury is a common problem that causes aesthetic distress and functional problems for those afflicted. Recently, pharmacological intervention of scar-promoting cellular activities has gained traction based on the emerging scientific evidence proving efficacy and safety of new therapeutics in preclinical studies. Ideal new drug therapies would be noninvasive, inexpensive, safe-to-use, and effective in prevention of scar formation. Recently, cytokine-based therapies and modulators of mechanotransduction are being evaluated for their anti-fibrotic properties in the reduction and prevention of scarring
Related Posts
TESA: Direct testicular sperm retrieval for IVF with minimal invasiveness
Testicular Sperm Aspiration (TESA) is a medical procedure employed to extract sperm directly from the testes. Typically performed on individuals experiencing sperm production abnormalities or genital obstructions hindering normal sperm release, it addresses fertility challenges. TESA involves the use of a specialized needle inserted beneath the scrotal skin or a minor surgical operation on the […]
Effective Strategies for Managing Bartholin’s Duct Cysts and Gland Abscesses
Bartholin’s duct cysts and gland abscesses are common problems that can affect women of reproductive age. Cysts are usually asymptomatic, but they can become enlarged or infected and cause significant pain and discomfort. Abscesses are always painful and require medical treatment. There are a number of effective strategies for managing Bartholin’s duct cysts and gland […]
Epithelia Provoke Inflammation in Response to Apoptosis
Apoptosis is a process of programmed cell death that is traditionally considered to be immunologically silent. This means that it does not trigger an inflammatory response from the immune system. However, a new study has shown that apoptosis can actually provoke inflammation in zebrafish and cell culture when apoptotic epithelial cells cannot be expelled from […]